Furthermore, experimental studies have demonstrated that plasma inflammatory biomarkers, such as C-reactive protein, reactive oxygen species, plasma fibrinogen, interleukin-6, tumor necrosis factor-alpha and plasminogen activator inhibitor-1 are elevated in individuals with NAFLD [16, 27, 28]. Here, IL6 is linked to metabolic dysfunction-associated steatotic liver disease.